Dow AgroSciences will work to restore Sulfoxaflor registrations

“As a result of the extensive data currently available on sulfoxaflor, Dow AgroSciences expects the pollinator protection concerns to be readily and thoroughly addressed by EPA through further review of scientific data.”  

Dow AgroSciences says it expects EPA will “readily and thoroughly” address the concerns that have led to a cancellation notice for Transform and other Sulfoxaflor-containing products extensively used by cotton and grain sorghum producers.

The cancellation notice came in response to a Sept. 10 Ninth Circuit Court of Appeals ruling vacating product registrations for sulfoxaflor. The court cited studies on the effect of sulfoxaflor on pollinators that were not completed before registrations were issued by EPA.

“As a result of the extensive data currently available on sulfoxaflor, Dow AgroSciences expects the pollinator protection concerns expressed in a recent Ninth Circuit Court of Appeals decision to be readily and thoroughly addressed by EPA through further review of scientific data,” the company said in a press release.

“Four full years of widespread U.S. product use – with additional use in Canada, Australia and other nations – have demonstrated excellent sulfoxaflor performance worldwide with no noted adverse effects on pollinators.

The statement said registrations outside the U.S. of sulfoxaflor-containing products should not be impacted by this decision, and U.S. tolerances for sulfoxaflor are similarly unaffected.

“As part of its recent action, EPA has issued an existing stocks provision allowing growers to use sulfoxaflor-containing products they have in hand consistent with directions on the pre-existing product label,” the statement said.

“Dow AgroSciences is, however, disappointed with EPA’s existing stocks provision which effectively removes a critical tool from the American grower by not allowing existing inventories of sulfoxaflor-containing products to be sold and distributed to end-users while EPA considers its next steps.”

Sources in the crop protection industry said that while the studies on the impact of sulfoxaflor on pollinators had not been completed when EPA approved a registration for the product, the studies were expected to show no adverse effect.

“In reviewing the documents, the court said EPA had not completed all the necessary studies as required by law and vacated the registration,” the source said. “This was an unusual step to say the least.”

Dow AgroSciences said it “remains confident in the benefits offered by this new class of insecticides and will work diligently with EPA and States to achieve new registrations for these important products to support the American grower.

Sulfoxaflor is a sulfoximine-class insecticide, the company also noted, and not a neonicotinoid as some environmental activist groups have claimed. “This is a distinction clearly established by the Insecticide Resistance Action Committee and published in the open scientific literature,” the company said.

To learn more about Transform, visit http://www.dowagro.com/en-US.

 

TAGS: Legislative
Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish